Valsartan is a generic version of Diovan (Valsartan) and Valsartan HCTZ is the generic version Co-Diovan (Valsartan HCTZ), both of which are from Novartis and are used to treat heart failure, hypertension and recent myocardial infarction.
Teva commercial director Kim Innes said the company has launched 19 products in 2011 including eight day one patent expiries in various strengths and pack sizes.
"It’s good for Pharmacy, because patent expiries provide them with the opportunities for increasing margins and keeping costs down," Innes added.